# Lithium

NDC: 0121-1027
Generic name: Lithium
Labeler / Manufacturer: PAI Holdings, LLC dba PAI Pharma
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20260414

FDA application: ANDA070755

## Active ingredients

- LITHIUM CITRATE: 8 meq/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0121-1027"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0121-1027
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=677b20c4-84f0-4716-aca3-aead3bbe1283